The Korean Journal of Physiology and Pharmacology

The Korean Society of Pharmacology (대한약리학회)
권호 표지

Gene Expression Profile in Microglia following Ischemia-Reperfusion Injury

  • Oh, Ju-Hyeon (Department of Physiology, School of Medicine, Kyungpook National University) ;
  • Han, Hyung-Soo (Department of Physiology, School of Medicine, Kyungpook National University) ;
  • Park, Jae-Sik (Department of Physiology, School of Medicine, Kyungpook National University)
  • Published : 2006.08.30
Download PDF
⟨ Previous Next ⟩

Abstract

Microglial activation is thought to play a role in the pathogenesis of many brain disorders. Therefore, understanding the response of microglia to noxious stimuli may provide insights into their role in disorders such as stroke and neurodegeneration. Many genes involved in this response have been identified individually, but not systematically. In this regards, the microarray system permitted to screen a large number of genes in biological or pathological processes. Therefore, we used microarray technology to evaluate the effect of oxygen glucose deprivation (OGD) and reperfusion on gene expression in microglia under ischemia-like and activating conditions. Primary microglial cultures were prepared from postnatal mice brain. The cells were exposed to 4 hrs of OGD and 1 h of reperfusion at $37^{\circ}C$. Isolated mRNA were run on GeneChips. After OGD and reperfusion, ＞2-fold increases of 90 genes and ＞2-fold decrease of 41 genes were found. Among the genes differentially increased by OGD and reperfusion in microglia were inflammatory and immune related genes such as prostaglandin E synthase, $IL-1{\beta}$, and $TNF-{\alpha}$. Microarray analysis of gene expression may be useful for elucidating novel molecular mediators of microglial reaction to reperfusion injury and provide insights into the molecular basis of brain disorders.

Keywords

References

  1. Asea A, Kraeft SK, Kurt-Jones EA, Stevenson MA, Chen LB, Finberg RW, Koo GC, Calderwood SK. Hsp70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med 6: 435-442, 2000 https://doi.org/10.1038/74697
  2. Banati RB, Rothe G, Valet G, Kreutzberg GW. Detection of lysosomal cysteine proteinases in microglia: flow cytometric measurement and histochemical localization of cathepsin B and L. Glia 7: 183-191, 1993 https://doi.org/10.1002/glia.440070208
  3. Brew K, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 1477: 267-283, 2000 https://doi.org/10.1016/S0167-4838(99)00279-4
  4. Colton CA, Gilbert DL. Production of superoxide anions by a CNS macrophage, the microglia. FEBS Lett 223: 284-288, 1987 https://doi.org/10.1016/0014-5793(87)80305-8
  5. Dahlquist KD, Salomonis N, Vranizan K, Lawlor SC, Conklin BR. GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat Genet 31: 19-20, 2002 https://doi.org/10.1038/ng0502-19
  6. Dickson DW, Lee SC, Mattiace LA, Yen SH, Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7: 75-83, 1993 https://doi.org/10.1002/glia.440070113
  7. El Khoury J, Hickman SE, Thomas CA, Loike JD, Silverstein SC. Microglia, scavenger receptors, and the pathogenesis of Alzheimer's disease. Neurobiol Aging 19(Suppl): 1-84, 1998 https://doi.org/10.1016/S0197-4580(98)00039-6
  8. Iadecola C, Forster C, Nogawa S, Clark HB, Ross ME. Cyclooxygenase-2 immunoreactivity in the human brain following cerebral ischemia. Acta Neuropathol (Berl) 98: 9-14, 1999 https://doi.org/10.1007/s004010051045
  9. Li C, Wong WH. Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application. Genome Biology 2: 1-11, 2001a
  10. Li C, Wong WH. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 98: 31-36, 2001b https://doi.org/10.1073/pnas.011404098
  11. Maeda A, Sobel RA. Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions. J Neuropathol Exp Neurol 55: 300-309, 1996 https://doi.org/10.1097/00005072-199603000-00005
  12. Nagayama M, Niwa K, Nagayama T, Ross ME, Iadecola C. The cyclooxygenase-2 inhibitor NS-398 ameliorates ischemic brain injury in wild-type mice but not in mice with deletion of the inducible nitric oxide synthase gene. J Cereb Blood Flow Metab 19: 1213-1219, 1999 https://doi.org/10.1038/sj.bmt.1700818
  13. Nogawa S, Forster C, Zhang F, Nagayama M, Ross ME, Iadecola C. Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia. Proc Natl Acad Sci USA 95: 10966-10971, 1998 https://doi.org/10.1073/pnas.95.18.10966
  14. Nogawa S, Zhang F, Ross ME, Iadecola C. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J Neurosci 17: 2746-2755, 1997 https://doi.org/10.1523/JNEUROSCI.17-08-02746.1997
  15. O'Banion MK. Cyclooxygenase-2: molecular biology, pharmacology, and neurobiology. Crit Rev Neurobiol 13: 45-82, 1999 https://doi.org/10.1615/CritRevNeurobiol.v13.i1.30
  16. Persidsky Y, Gendelman HE. Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection. J Leukoc Biol 74: 691-701, 2003 https://doi.org/10.1189/jlb.0503205
  17. Raghavendra Rao VL, Bowen KK, Dhodda VK, Song G, Franklin JL, Gavva NR, Dempsey RJ. Gene expression analysis of spontaneously hypertensive rat cerebral cortex following transient focal cerebral ischemia. J Neurochem 83: 1072-1086, 2002 https://doi.org/10.1046/j.1471-4159.2002.01208.x
  18. Rosenberg GA. Matrix metalloproteinases in neuroinflammation. Glia 39: 279-291, 2002 https://doi.org/10.1002/glia.10108
  19. Sairanen T, Ristimaki A, Karjalainen-Lindsberg ML, Paetau A, Kaste M, Lindsberg PJ. Cyclooxygenase-2 is induced globally in infarcted human brain. Ann Neurol 43: 738-747, 1998 https://doi.org/10.1002/ana.410430608
  20. Stenzel-Poore MP, Stevens SL, Xiong Z, Lessov NS, Harrington CA, Mori M, Meller R, Rosenzweig HL, Tobar E, Shaw TE, Chu X, Simon RP. Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet 362: 1028-1037, 2003 https://doi.org/10.1016/S0140-6736(03)14412-1
  21. Thomas WE. Brain macrophages: evaluation of microglia and their functions. Brain Res Brain Res Rev 17: 61-74, 1992 https://doi.org/10.1016/0165-0173(92)90007-9
  22. Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 38: 97-120, 1998 https://doi.org/10.1146/annurev.pharmtox.38.1.97
  23. Yenari MA, Giffard RG. Ischemic vulnerability of primary murine microglial cultures. Neurosci Lett 298: 5-8, 2001 https://doi.org/10.1016/S0304-3940(00)01724-9